470 related articles for article (PubMed ID: 28645211)
21. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
[TBL] [Abstract][Full Text] [Related]
22. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.
Nohara K; Waraich RS; Liu S; Ferron M; Waget A; Meyers MS; Karsenty G; Burcelin R; Mauvais-Jarvis F
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1321-30. PubMed ID: 23612996
[TBL] [Abstract][Full Text] [Related]
23. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
24. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer.
Liu C; Armstrong CM; Lou W; Lombard A; Evans CP; Gao AC
Mol Cancer Ther; 2017 Jan; 16(1):35-44. PubMed ID: 27794047
[TBL] [Abstract][Full Text] [Related]
26. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
Lecke SB; Morsch DM; Spritzer PM
Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
[TBL] [Abstract][Full Text] [Related]
27. Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study.
Gashaw I; Reif S; Wiesinger H; Kaiser A; Zollmann FS; Scheerans C; Grevel J; Piraino P; Seidel H; Peters M; Rottmann A; Rohde B; Arlt W; Hilpert J
Eur J Endocrinol; 2023 Jul; 188(7):578-591. PubMed ID: 37306288
[TBL] [Abstract][Full Text] [Related]
28. Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.
Quinkler M; Sinha B; Tomlinson JW; Bujalska IJ; Stewart PM; Arlt W
J Endocrinol; 2004 Nov; 183(2):331-42. PubMed ID: 15531721
[TBL] [Abstract][Full Text] [Related]
29. AMPK Activation Is Important for the Preservation of Insulin Sensitivity in Visceral, but Not in Subcutaneous Adipose Tissue of Postnatally Overfed Rat Model of Polycystic Ovary Syndrome.
Mićić B; Teofilović A; Djordjevic A; Veličković N; Macut D; Vojnović Milutinović D
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012206
[TBL] [Abstract][Full Text] [Related]
30. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study.
Lecke SB; Morsch D; Spritzer PM
Reprod Biol Endocrinol; 2013 Aug; 11():77. PubMed ID: 23941060
[TBL] [Abstract][Full Text] [Related]
32. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome.
Godoy-Matos AF; Vaisman F; Pedrosa AP; Farias ML; Mendonça LM; Pinheiro MF
Gynecol Endocrinol; 2009 Dec; 25(12):793-8. PubMed ID: 19905998
[TBL] [Abstract][Full Text] [Related]
33. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
34. AKR1C3 as a target in castrate resistant prostate cancer.
Adeniji AO; Chen M; Penning TM
J Steroid Biochem Mol Biol; 2013 Sep; 137():136-49. PubMed ID: 23748150
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer.
Himura R; Kawano S; Nagata Y; Kawai M; Ota A; Kudo Y; Yoshino Y; Fujimoto N; Miyamoto H; Endo S; Ikari A
Chem Biol Interact; 2024 Jan; 388():110840. PubMed ID: 38122923
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
[TBL] [Abstract][Full Text] [Related]
37. Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue.
Nikolić M; Macut D; Djordjevic A; Veličković N; Nestorović N; Bursać B; Antić IB; Macut JB; Matić G; Vojnović Milutinović D
Mol Cell Endocrinol; 2015 Jan; 399():22-31. PubMed ID: 25179821
[TBL] [Abstract][Full Text] [Related]
38. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
[TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
[TBL] [Abstract][Full Text] [Related]
40. The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.
Tamae D; Mostaghel E; Montgomery B; Nelson PS; Balk SP; Kantoff PW; Taplin ME; Penning TM
Chem Biol Interact; 2015 Jun; 234():332-8. PubMed ID: 25514466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
